State Street’s Acutus Medical Inc AFIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-51,871
| Closed | -$9.75K | – | 4440 |
|
|
2024
Q1 | $9.75K | Hold |
51,871
| – | – | ﹤0.01% | 4326 |
|
|
2023
Q4 | $10.5K | Hold |
51,871
| – | – | ﹤0.01% | 4393 |
|
|
2023
Q3 | $36.1K | Hold |
51,871
| – | – | ﹤0.01% | 4354 |
|
|
2023
Q2 | $46.1K | Sell |
51,871
-4,200
| -7% | -$3.56K | ﹤0.01% | 4443 |
|
|
2023
Q1 | $42.3K | Hold |
56,071
| – | – | ﹤0.01% | 4544 |
|
|
2022
Q4 | $64.5K | Hold |
56,071
| – | – | ﹤0.01% | 4491 |
|
|
2022
Q3 | $49K | Sell |
56,071
-635
| -1% | -$769 | ﹤0.01% | 4663 |
|
|
2022
Q2 | $64K | Sell |
56,706
-374,159
| -87% | -$321K | ﹤0.01% | 4670 |
|
|
2022
Q1 | $599K | Buy |
430,865
+42,578
| +11% | +$91K | ﹤0.01% | 3972 |
|
|
2021
Q4 | $1.32M | Buy |
388,287
+60,031
| +18% | +$338K | ﹤0.01% | 3748 |
|
|
2021
Q3 | $2.9M | Buy |
328,256
+109,588
| +50% | +$1.44M | ﹤0.01% | 3508 |
|
|
2021
Q2 | $3.71M | Buy |
218,668
+37,557
| +21% | +$549K | ﹤0.01% | 3377 |
|
|
2021
Q1 | $2.42M | Buy |
181,111
+18,400
| +11% | +$414K | ﹤0.01% | 3359 |
|
|
2020
Q4 | $4.69M | Buy |
162,711
+42,273
| +35% | +$1.14M | ﹤0.01% | 2995 |
|
|
2020
Q3 | $3.59M | Buy |
+120,438
| New | +$3.66M | ﹤0.01% | 2945 |
|
Other funds holding AFIB
State Street's AFIB Position: Q2 2024 in Review
State Street sold out of Acutus Medical Inc (AFIB) in Q2 2024, closing a stake of 51,871 shares — an estimated $9.75K sold.
State Street first reported a position in AFIB in Q3 2020 and held it in 15 quarters. The position peaked at $4.69M in Q4 2020. 1 fund tracked by Wall St. Rank holds AFIB as of Q2 2024.
- State Street reported no remaining Acutus Medical Inc position as of Q2 2024 after selling out during the quarter.
- State Street sold 51,871 Acutus Medical Inc shares in Q2 2024, an estimated $9.75K.
- State Street first reported a position in Acutus Medical Inc in Q3 2020 and held it in 15 quarters.
- State Street's Acutus Medical Inc position peaked at $4.69M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2024.
Based on State Street's 13F filing for Q2 2024, filed 14 Aug 2024.